Nucleotide sequence analysis of an HLA-B47 variant (HLA-B(*)4702)

Tissue Antigens

Volumn 49, Issue 5, 1997, Pages 540-542

  Fischer, G F ^a   Broer, E ^a   Fae I ^a   Leitner, D ^b   Mayr, W R ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b Blutzentrale Linz   (Austria)

Author keywords

HLA B47; Nucleotide sequence analysis

Indexed keywords

COMPLEMENTARY DNA; EPITOPE; HLA B ANTIGEN;

ARTICLE; GENE SEQUENCE; HISTOCOMPATIBILITY GENE; HLA SYSTEM; HUMAN; NOMENCLATURE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

EID: 0031009505     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1997.tb02797.x     Document Type: Article

References (4)

1. Bodmer JG, Marsh SGE, Albert ED et al. Nomenclature for the factors of the HLA system, 1995. Tissue Antigens 1995: 46: 1-18.
2. Craxton M. Linear amplification sequencing, a powerful method for sequencing. Methods Enzymol 1991: 3: 20-26.
3. Müller CA, Engler BG, Gekeler V, Steiert I, Weiss E, Schmidt H. Genetic and serological heterogeneity of the supertypic HLA-B locus specificities Bw4 and Bw6. Immunogenetics 1989: 30: 200-7.
4. Wan AM, Ennis P, Parham P, Holmes N. The primary structure of HLA-A32 suggests a region involved in formation of the Bw4/Bw6 epitopes. J Immunol 1986: 137: 3671-4.